Answers are grounded in this paper and cite their sources.
New organoiridium complex shows enhanced luminescence in acidic conditions, suggesting potential for imaging cervical cancer cells.
In this work, the rational design and synthesis of a new green emissive cyclometalated iridium(III) complex‐based AIEgen 1[PF 6 ] containing a piperazine‐substituted 1,10‐phenanthroline ligand is presented. 1[PF 6 ] was fully characterized by NMR spectroscopic and ESI‐MS spectrometric studies. The photophysical properties of 1[PF 6 ] were examined by UV‐vis and PL spectroscopic studies. The electronic transitions associated with the absorption and emission spectra of 1[PF 6 ] in acetonitrile were predicted using standard computational methods. While 1[PF 6 ] was weakly emissive in acetonitrile, a significantly enhanced emissive pattern was observed in water and polyethylene glycol (PEG), indicating the aggregation‐induced emission (AIE) phenomenon. The formation of aggregated particles from 1[PF 6 ] was evidenced by UV‐vis spectroscopy, DLS, SEM, and TEM studies. Interestingly, the pH‐responsive modulation of the luminescence intensity of 1[PF 6 ] in the aqueous medium, as well as in the fabricated portable paper strips, highlighted a higher emission profile in the slightly acidic medium (pH: 3–5) with a reduced emission intensity pattern towards the neutral to alkaline medium. Moreover, the biocompatibility of 1[PF 6 ] was assessed in a representative cervical cancer cell line (HeLa) with intense green emission and a low cytotoxicity profile, indicating the potential real‐time application of 1[PF 6 ] as a pH‐responsive AIEgen in the future.
No takes yet. Share an insight, caveat, or question.
Kashyap et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: